Electrospun Fibrous Matrix for Medical Electrical Lead Electrode Coating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional medical electrodes face challenges in controlling tissue ingrowth, inflammation, and reduced electrode performance over time due to polarization and impedance issues at the electrode/tissue interface, making it difficult to extract and maintain optimal electrical performance.
Innovation Solution
A medical electrical lead with a fibrous matrix composed of poly(vinylidene fluoride-co-hexafluoropropene) (PVDF HFP) or other non-conductive polymers, such as polyurethane, is coated over the electrode using electrospinning or meltblowing techniques, with controlled fiber diameters and spacing to manage tissue ingrowth and maintain electrical performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional materials are used as electrodes, then electrode performance can be maintained initially, but tissue in-growth, inflammation, and fibrous scar tissue formation occur over time leading to reduced performance and difficulty in extraction
Solution Approach 1:
A fibrous matrix is applied to the electrode surface before implantation to preemptively control tissue interaction. The matrix is pre-formed with specific fiber diameter (50-500 nm) and porosity characteristics that are designed to guide tissue ingrowth patterns and reduce inflammatory response before the implantation process begins
Solution Approach 2:
The fibrous matrix modifies the physical and chemical parameters of the electrode-tissue interface by introducing controlled porosity (40-80% void space), specific surface area, and fiber diameter parameters. These parameter changes create a more favorable environment for tissue integration while maintaining electrical performance characteristics
2Object-affected harmful factors
If a coating is applied to control tissue in-growth, then extraction difficulty may increase, but the coating must remain thin enough to maintain electrical performance
Solution Approach 1:
The fibrous matrix provides locally optimized properties at the electrode-tissue interface, with different regions of the matrix having tailored fiber diameters, porosity, and material composition. This local quality variation allows control of tissue ingrowth in specific areas while maintaining electrical contact in other regions
Solution Approach 2:
The fibrous matrix is designed with high porosity (40-80% void space) and interconnected pore structures that allow electrical signals to penetrate through the coating to reach the underlying electrode. The porous structure enables tissue ingrowth control while maintaining electrical performance by allowing field penetration and ionic conduction
3Object-affected harmful factors
If fiber diameter is reduced to control tissue in-growth, then manufacturing precision requirements increase, but larger fibers may allow better electrical signal transmission
Solution Approach 1:
Traditional mechanical fiber formation methods are replaced with electrospinning technology, which uses electrical fields to draw and deposit polymer fibers. This substitution enables precise control of fiber diameter (50-500 nm) through electrical parameter control rather than mechanical constraints, achieving the required manufacturing precision
Solution Approach 2:
The manufacturing process controls fiber diameter by adjusting multiple parameters including polymer solution concentration, electrical field strength, deposition distance, and solvent evaporation rate. These parameter changes enable precise control of fiber dimensions while maintaining manufacturing feasibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The fibrous matrix improves tissue ingrowth control, reduces extraction force, and maintains electrophysiological therapy delivery without significantly impacting impedance, enhancing the longevity and effectiveness of the electrode.
Implementation Method 1
forming a fibrous matrix including a non-conductive polymer by electrospinning
Implementation Method 2
forming a fibrous matrix including a non-conductive polymer by electrospinning or meltblowing
Data Source
AI summary
A medical electrical lead may include an insulative lead body, a conductor disposed within the insulative lead body, an electrode disposed on the insulative lead body and in electrical contact with the conductor and a fibrous matrix disposed at least partially over the electrode. The fibrous matrix may be formed from a non-conductive polymer.


